Alectinib for relapsed or refractory ALK-positive anaplastic large cell lymphoma: an open label phase 2 trial
| Image |  |
|---|---|
| Description | scientific article published on 03 October 2020 |
| Author/s |
author: Kengo Takeuchi Reiji Fukano |
| Publication date | October 3, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |